AgeX Therapeutics Inc. (AGE)

AI Score

Unlock

11.10

-1.50 (-11.90%)

At close: Mar 26, 2024, 7:59 PM

AgeX Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018
Period Ending	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018
Net Income	-9.44M	-3.46M	-5.39M	-2.68M	-3.29M	-2.76M	-2.44M	-2.62M	-2.71M	-2.16M	-1.96M	-2.48M	-1.99M	-2.46M	-2.56M	-2.73M	-3.22M	-2.74M	-3.28M	-3.15M	-3.21M	-3.27M	-2.19M	-1.95M	-321K
Depreciation & Amortization	25K	33K	33K	32K	33K	33K	33K	33K	33K	33K	32K	33K	33K	577K	370K	368K	367K	294K	257K	251K	149K	150K	146K	117K	122K
Stock-Based Compensation	53K	503K	40K	35K	70K	114K	209K	198K	239K	263K	272K	286K	178K	182K	232K	259K	260K	420K	491K	515K	481K	797K	210K	231K	235K
Other Working Capital	n/a	633K	-234K	174K	-202K	147K	18K	63K	-64K	-53K	-139K	88K	-1.79M	328K	-83K	46K	15K	98K	-17K	-213K	44K	44K	-49K	-375K	92K
Other Non-Cash Items	n/a	1.13M	3.19M	919K	1.09M	921K	831K	979K	631K	294K	283K	707K	-170K	210K	147K	83K	47K	101K	-80K	-396K	29K	-109K	-30K	-72K	800K
Deferred Income Tax	n/a	-734K	-175K	-199K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-437K	-196K	61K	14K	39K	5K	-73K	56K	66K	73K	88K	34K	21K	-3.21M
Change in Working Capital	n/a	468K	433K	-127K	230K	372K	127K	-338K	168K	-78K	-516K	192K	-482K	-192K	-87K	-262K	479K	-412K	181K	-40K	-139K	302K	42K	-507K	374K
Operating Cash Flow	-1.58M	-2.05M	-1.86M	-2.02M	-1.86M	-1.32M	-1.24M	-1.75M	-1.64M	-1.65M	-1.88M	-1.69M	-2.63M	-1.62M	-1.89M	-2.24M	-2.06M	-2.41M	-2.37M	-2.76M	-2.62M	-2.05M	-1.78M	-2.16M	-2M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	20K	-12K	-4K	-4K	-295K	-237K	-106K	-3K	1.89M	-1.08M	-12K	-801K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-466K	n/a	n/a	466K	n/a	n/a	n/a	n/a	-354K	77K	277K	n/a	-3.21M	n/a	n/a	3.21M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-14K	n/a	n/a	n/a	-10M	n/a	n/a	n/a	n/a	716K	n/a	n/a	-50K	n/a	n/a	n/a	n/a	354K	3K	-77K	n/a	1.32M	2K	n/a	n/a
Investing Cash Flow	-14K	n/a	n/a	n/a	-10M	n/a	n/a	n/a	n/a	250K	n/a	n/a	416K	20K	-12K	-4K	-4K	-295K	-157K	94K	-3K	3K	-1.08M	-12K	2.41M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.73M	2M	2M	2M	11.5M	1.5M	1M	2M	1.5M	1.25M	2M	1.5M	2.5M	992K	1.98M	2.81M	185K	1.29M	487K	-9K	4.5M	n/a	263K	5M	737K
Financial Cash Flow	2.73M	2M	2M	2M	11.5M	1.5M	1M	2M	1.5M	1.25M	2M	1.5M	2.5M	992K	1.98M	2.81M	185K	1.29M	487K	-9K	4.5M	n/a	263K	5M	737K
Net Cash Flow	1.14M	-52K	136K	-19K	-365K	179K	-236K	254K	-136K	-147K	116K	-194K	282K	-630K	74K	565K	-1.88M	-1.42M	-2.04M	-2.67M	1.88M	-2.05M	-2.6M	2.83M	1.15M
Free Cash Flow	-1.58M	-2.05M	-1.86M	-2.02M	-1.86M	-1.32M	-1.24M	-1.75M	-1.64M	-1.65M	-1.88M	-1.69M	-2.63M	-1.6M	-1.9M	-2.25M	-2.07M	-2.71M	-2.61M	-2.87M	-2.62M	-153K	-2.86M	-2.17M	-2.81M